DK452485A - Farmaceutisk praeparat indeholdende interferon-gamma (ifn-gamma) - Google Patents

Farmaceutisk praeparat indeholdende interferon-gamma (ifn-gamma) Download PDF

Info

Publication number
DK452485A
DK452485A DK452485A DK452485A DK452485A DK 452485 A DK452485 A DK 452485A DK 452485 A DK452485 A DK 452485A DK 452485 A DK452485 A DK 452485A DK 452485 A DK452485 A DK 452485A
Authority
DK
Denmark
Prior art keywords
gamma
pharmaceutical preparation
preparation containing
containing interferon
ifn
Prior art date
Application number
DK452485A
Other languages
English (en)
Other versions
DK174585B1 (da
DK452485D0 (da
Inventor
Josef Dr Brzoska
Johann-Friedrich Von Eichborn
Hans-Joachim Dr Obert
Original Assignee
Bioferon Biochem Substanz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27192400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK452485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19843436637 external-priority patent/DE3436637A1/de
Priority claimed from DE3436638A external-priority patent/DE3436638C2/de
Priority claimed from DE19853521733 external-priority patent/DE3521733A1/de
Application filed by Bioferon Biochem Substanz filed Critical Bioferon Biochem Substanz
Publication of DK452485D0 publication Critical patent/DK452485D0/da
Publication of DK452485A publication Critical patent/DK452485A/da
Application granted granted Critical
Publication of DK174585B1 publication Critical patent/DK174585B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198504524A 1984-10-05 1985-10-04 Anvendelse af gamma-inteferon til fremstilling af farmaceutiske præparater til systemisk behandling af forskellige sygdomme hos mennesker i lave doser DK174585B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE19843436637 DE3436637A1 (de) 1984-10-05 1984-10-05 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung von schmerzen
DE3436638 1984-10-05
DE3436638A DE3436638C2 (de) 1984-10-05 1984-10-05 Verwendung von Interferon-gamma (IFN-gamma) enthaltenden Präparationen zur Behandlung rheumatischer Erkrankungen
DE3436637 1984-10-05
DE19853521733 DE3521733A1 (de) 1985-06-18 1985-06-18 Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von tumoren und viruserkrankungen in niedriger dosierung
DE3521733 1985-06-18

Publications (3)

Publication Number Publication Date
DK452485D0 DK452485D0 (da) 1985-10-04
DK452485A true DK452485A (da) 1986-04-06
DK174585B1 DK174585B1 (da) 2003-07-07

Family

ID=27192400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198504524A DK174585B1 (da) 1984-10-05 1985-10-04 Anvendelse af gamma-inteferon til fremstilling af farmaceutiske præparater til systemisk behandling af forskellige sygdomme hos mennesker i lave doser

Country Status (6)

Country Link
US (1) US5145677A (da)
EP (2) EP0181455B2 (da)
CA (1) CA1288694C (da)
DE (1) DE3583849D1 (da)
DK (1) DK174585B1 (da)
IL (2) IL76591A0 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149551A3 (en) * 1984-01-16 1987-09-23 Genentech, Inc. Gamma interferon-interleukin-2 synergistic compositions and processes therefor
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
WO1987005518A1 (en) * 1986-03-17 1987-09-24 Schering Corporation Treatment of cancers with gamma interferon
WO1987007842A1 (en) * 1986-06-17 1987-12-30 Biogen N.V. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents and methods for treating diseases
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
EP0278715A3 (en) * 1987-02-09 1989-03-08 Schering Corporation Use of human gamma interferon for treatment of basal cell carcinoma
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
WO1989008461A1 (en) * 1988-03-07 1989-09-21 Centocor, Inc. Interferon gamma composition to suppress immune system
FR2644067B1 (fr) * 1989-02-02 1993-02-05 Roussel Uclaf Utilisation de certains interferons gamma pour la preparation de compositions pharmaceutiques destinees au traitement du cancer de l'ovaire par voie intraperitoneale
ATE121945T1 (de) * 1989-12-01 1995-05-15 Childrens Medical Center Verwendung von gamma-interferon zur herstellung eines medikaments für die behandlung von steroid- abhängigem asthma.
US5849282A (en) * 1990-05-09 1998-12-15 Otsuka Pharmaceutical Co., Ltd. Method of treating colon, renal, and lung carcinomas with γ-interferon and Ser71 !-interleukin-1β
JP2587711B2 (ja) * 1990-05-09 1997-03-05 大塚製薬 株式会社 抗腫瘍剤
US5681555A (en) * 1991-04-22 1997-10-28 Gleich; Gerald J. Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
TW218846B (da) * 1992-04-07 1994-01-11 Ciba Geigy
EP0704220A1 (de) * 1994-09-30 1996-04-03 Dr. Rentschler Biotechnologie GmbH Verwendung von Interferon beta enthaltenden Arzneimitteln
JP3834084B2 (ja) * 1995-09-07 2006-10-18 第一アスビオファーマ株式会社 痒疹治療剤
DE69632062T2 (de) 1995-11-02 2004-11-18 Schering Corp. Kontinuierliche, niedrigdosierte zytokine-infusionstherapie
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
US20030108519A1 (en) * 1996-05-09 2003-06-12 Pharma Pacific Pty Ltd. Therapeutic applications of high dose in terferon
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
IL126971A0 (en) * 1996-05-09 1999-09-22 Pharma Pacific Pty Ltd Interferon compositions
PT1974747E (pt) 1998-08-11 2012-09-05 Biogen Idec Inc Terapias de combinação para linfomas de células b compreendendo a administração de anticorpo anti-cd20
HK1041811A1 (zh) * 1998-11-09 2002-07-26 Idec药物公司 接受bmt或pbsc移植患者的抗cd20嵌合抗体治疗
RU2140286C1 (ru) * 1999-04-28 1999-10-27 Гапонюк Петр Яковлевич Противовирусное средство - глазные капли "офтальмоферон"
US20040228871A1 (en) * 1999-06-03 2004-11-18 Tayyaba Hasan Treatment and analysis of proliferative disorders
EP1066834A3 (de) * 1999-07-08 2004-06-02 Thomas Dr. Stief Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
CA2387089A1 (en) * 1999-11-10 2001-05-17 Mondobiotech Sa Interferon gamma for the treatment of asthma
WO2001041782A2 (en) * 1999-12-09 2001-06-14 Chiron Corporation Method for administering a cytokine to the central nervous system and the lymphatic system
WO2001074384A1 (en) * 2000-03-31 2001-10-11 Aronex Pharmaceuticals, Inc. Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use
AU2001297807A1 (en) * 2000-12-20 2002-11-11 Sri International Modulators of the hypocretin system and methods of screening therefor
JP2005515161A (ja) * 2001-06-14 2005-05-26 インターミューン インコーポレイテッド γ−インターフェロンおよびＢ細胞特異的抗体の併用療法
WO2003007981A1 (en) * 2001-07-20 2003-01-30 Intermune, Inc. Methods of treating liver fibrosis
US6911198B2 (en) * 2001-09-17 2005-06-28 Yeda Research And Development Co. Ltd. Method and pharmaceutical composition for treating inflammation
IL161022A0 (en) * 2001-10-05 2004-08-31 Intermune Inc Methods of treating liver fibrosis and hepatitis c virus infection
AU2003253888A1 (en) * 2002-07-15 2004-02-02 Gilead Sciences, Inc. Combination therapies with l-fmau for the treatment of hepatitis b virus infection
EP1551369A4 (en) * 2002-08-28 2007-05-09 Intermune Inc COMBINATION THERAPY FOR THE TREATMENT OF FIBROTIC DISEASES
EP1430902A1 (en) * 2002-12-20 2004-06-23 Mondobiotech Laboratories Anstalt Pharmaceutical composition of interferon gamma with molecular diagnostics for the improved treatment of asthma bronchiale
CA2511209A1 (en) * 2002-12-26 2004-07-15 Daiichi Suntory Pharma Co., Ltd. Agent for treatment of pemphigoid
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12377112B2 (en) 2019-04-17 2025-08-05 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
JP7840267B2 (ja) * 2020-03-06 2026-04-03 サントル、オスピタリエ、ユニヴェルシテール、ド、ニーム 筋萎縮性側索硬化症の治療のための低用量ヒトインターロイキン－２
WO2023072863A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
US4460685A (en) 1980-05-29 1984-07-17 New York University Method of enhancing the production of human γ Interferon
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
US4376821A (en) 1981-04-17 1983-03-15 Meloy Laboratories, Inc. Production of human IFN-gamma (immune) interferon
EP0090837A1 (en) * 1981-10-08 1983-10-12 BERG, Kurt Frimann Method and composition for treating a patient suffering from interferonsusceptible disorder
EP0077063B1 (en) 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
EP0080032A3 (en) 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
EP0107498B1 (en) * 1982-10-25 1990-05-16 Genentech, Inc. Synergistic human interferon activity
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
US4461757A (en) 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
IL71954A0 (en) * 1983-06-01 1984-09-30 Genentech Inc Gamma interferon-lymphotoxin synergism
CA1265444A (en) * 1983-06-27 1990-02-06 Lloyd J. Old Effect of human tumor necrosis factor and human interferon on human cancer cells and methods
EP0149551A3 (en) * 1984-01-16 1987-09-23 Genentech, Inc. Gamma interferon-interleukin-2 synergistic compositions and processes therefor
US4946674A (en) * 1984-10-05 1990-08-07 Bioferon Biochemische Substanzen Gmbh & Co. Process for treatment of rheumatic diseases
FR2611031B1 (fr) * 1987-02-16 1989-05-05 Commissariat Energie Atomique Refrigerateur, notamment a cycle de vuilleumier, comportant des pistons suspendus par des paliers a gaz

Also Published As

Publication number Publication date
US5145677A (en) 1992-09-08
IL76591A (en) 1991-06-10
DK174585B1 (da) 2003-07-07
EP0181455A3 (en) 1986-06-04
DE3583849D1 (de) 1991-09-26
AU588547B2 (en) 1989-09-21
DK452485D0 (da) 1985-10-04
CA1288694C (en) 1991-09-10
EP0177910A3 (de) 1986-07-02
IL76591A0 (en) 1986-02-28
EP0181455B2 (de) 2000-05-31
EP0177910A2 (de) 1986-04-16
EP0181455B1 (de) 1991-08-21
EP0181455A2 (de) 1986-05-21
AU4841285A (en) 1986-04-10

Similar Documents

Publication Publication Date Title
DK452485A (da) Farmaceutisk praeparat indeholdende interferon-gamma (ifn-gamma)
GR862727B (en) Pharmaceutical preparation
DK118086A (da) Farmaceutiske praeparater, der indeholder antivirale nucleosider
ZA867318B (en) Pharmaceutical composition
DK481585D0 (da) Farmaceutisk praeparat indeholdende anthracyclinglycosider
GB8602788D0 (en) Pharmaceutical composition
DK28985D0 (da) Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf
IL79309A0 (en) (heterocyclic substituted-phenoxy)alkyl-isoxazoles and-furans,their preparation and pharmaceutical compositions containing them
KR890701135A (ko) 감마 인터페론 제제
DK259186D0 (da) Nasale farmaceutiske praeparater
IL79376A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
AU6397986A (en) Derivatives of gamma ifn
DK131986A (da) Stabilt gammainterferonpraeparat
NZ215910A (en) Cyclopentyl ethers and pharmaceutical compositions
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
GB8623389D0 (en) Pharmaceutical formulations
GB2184119B (en) Preparation of aliphatic tertiary amines
IL79377A0 (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL78918A0 (en) Substituted hexahydro-arylquinolizines and pharmaceutical compositions containing them
IL74168A0 (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
IL79535A0 (en) Acylphosphorotriamides and pharmaceutical compositions containing them
ZA862140B (en) Stable gamma interferon formulation
AU6605686A (en) Bovine gamma ifn
DK156771C (da) Bis-dioxopiperazin-derivater med antitumor-aktivitet og laegemiddelformuleringer indeholdende saadanne forbindelser
IL80338A0 (en) Bicycle-substituted phenylacetonitrile derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A0 Application filed
PUP Patent expired